NIH Guide: Weekly Index for June 11, 2021

Funding Opportunities

• Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional)
  (PAR-21-138)
  National Cancer Institute
  Application Receipt Date(s): The first Application Due Date is July 7, 2021. NCI ESI MERIT Award Extension requests are due during the penultimate award year, either on March 1, July 1, or November 1. For more details, refer to the deadlines table for the NCI ESI MERIT Awards. Recipients are encouraged to contact the NCI program director and grants management specialist assigned to the R37 award for details. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)
  (PAR-21-244)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed)
  (RFA-AG-22-003)
  National Institute on Aging
  Application Receipt Date(s): October 4, 2021.
• NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed)
  (RFA-AG-22-004)
  National Institute on Aging
  Application Receipt Date(s): September 29, 2021.
• NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional)
  (RFA-AG-22-007)
  National Institute on Aging
  Application Receipt Date(s): October 26, 2021
• NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)
  (RFA-AG-22-014)
  National Institute on Aging
  Application Receipt Date(s): October 26, 2021
• High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed)
  (RFA-AG-22-019)
  National Institute on Aging
  Application Receipt Date(s): October 28, 2021
• Promoting Bunyavirales Basic Science Research (R01 Clinical Trial Not Allowed)
  (RFA-AI-21-046)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): October 22, 2021
• BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
  (RFA-NS-21-026)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Multiple dates, see announcement.
• BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
  (RFA-NS-21-027)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Multiple dates, see announcement.
• HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)
  (RFA-NS-21-029)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Integration, Dissemination, and Evaluation (BRIDGE) Center for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (U54 Clinical Trial Not Allowed)
  (RFA-RM-21-023)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): August 20, 2021